Sociable Pharma conducted in-depth primary research in the US and across Europe with seven key opinion leaders in juvenile idiopathic arthritis (JIA) to understand how therapy use will change in the future. A key theme in our research is the management and implementation of ‘step-up’ treatment strategies to optimize the timing of effective forms of therapy. Our view is that this is the major macro-trend that will alter treatment strategy, generating new treatment challenges and presenting opportunities for current and future market players. http://www.bharatbook.com/detail.asp?id=215245&rt=Juvenile-Idiopathic-Arthritis-JIAKOL-insights-on-treatment-practices-and-unmet-needs.htmlUnderstand key treatment trends including
* Aggressive versus conservative approaches
* Strategies for treating oligoarthritis, polyarthritis and systemic arthritis
* Long-term patient management on biologic therapies
market research reports
Identify unmet needs including
* Managing corticosteroid therapy
* Initiating methotrexate
* Initiating biologic therapy
* Treating sacroiliac juvenile arthritis
* Discontinuing methotrexate and biologics: managing patients with inactive disease
* Treating patients with systemic JIA
Table of Contents:
Executive Summary
Scope of Analysis & Methodology
Current Treatment practice
Synthetic DMARDs
Anti-TNF therapies
Anti-interleukins
Anti-CD20 antibodies
Other biologics
Corticosteroids
NSAIDs
Treatment Challenges / Unmet Needs
Juvenile Idiopathic Arthritis Treatment Map
For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=215245&rt=Juvenile-Idiopathic-Arthritis-JIAKOL-insights-on-treatment-practices-and-unmet-needs.html
Or
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668 / +91 22 27579438
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B